Rest pain or tissue loss due to PAD (Fontaine stage III and IV),
acute lower extremity ischemic event secondary to thromboembolic disease or acute trauma,
Walking capacity significantly limited by conditions other than claudication including leg (joint/musculoskeletal, neurologic) and systemic (heart, lung disease) pathology,
Current use of either ACE inhibitors or angiotensin II receptor blockers,
Chronic kidney disease with estimated Glomerular Filtration Rate < 30 ml/min/1.73 m2,
History of bilateral severe renal artery stenosis and 7) History of angioedema related to previous ACE-inhibitor treatment or known hypersensitivity to ramipril or other ACE inhibitors.
